ATOSSA THERAPEUTICS, INC. Proceeds from (Repayments of) Related Party Debt
ATOSSA THERAPEUTICS, INC. (ATOS) reported Proceeds from (Repayments of) Related Party Debt of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2014-05-14
- ATOSSA THERAPEUTICS, INC. proceeds from (repayments of) related party debt for the quarter ending 2014-03-31 was $0.00.
- ATOSSA THERAPEUTICS, INC. proceeds from (repayments of) related party debt for the quarter ending 2013-12-31 was $0.00.
- ATOSSA THERAPEUTICS, INC. proceeds from (repayments of) related party debt for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. proceeds from (repayments of) related party debt for the quarter ending 2013-06-30 was $0.00.
- ATOSSA THERAPEUTICS, INC. proceeds from (repayments of) related party debt for fiscal 2013 was $0.00.
- ATOSSA THERAPEUTICS, INC. proceeds from (repayments of) related party debt for fiscal 2012 was -$5.08K.
- ATOSSA THERAPEUTICS, INC. proceeds from (repayments of) related party debt for fiscal 2011 was -$183.92K.
| Period end | Proceeds from (Repayments of) Related Party Debt 3 month | Proceeds from (Repayments of) Related Party Debt 6 month | Proceeds from (Repayments of) Related Party Debt 9 month | Proceeds from (Repayments of) Related Party Debt 12 month | Proceeds from (Repayments of) Related Party Debt 41 month | Proceeds from (Repayments of) Related Party Debt 44 month | Proceeds from (Repayments of) Related Party Debt 47 month | Proceeds from (Repayments of) Related Party Debt 50 month | Proceeds from (Repayments of) Related Party Debt 53 month | Proceeds from (Repayments of) Related Party Debt 56 month | Proceeds from (Repayments of) Related Party Debt 59 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | -$2.00K 10-Q · filed 2014-05-14 | ||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $0.00 derived: sum of 2 quarters · filed 2014-03-27 | $0.00 derived: sum of 3 quarters · filed 2014-03-27 | $0.00 10-K · filed 2014-03-27 | -$2.00K 10-K · filed 2014-03-27 | ||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | -$80.45K derived: sum of 4 quarters · filed 2014-05-14 | -$2.00K 10-Q · filed 2013-11-12 | ||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | -$80.45K derived: sum of 3 quarters · filed 2014-05-14 | $1.10K derived: sum of 4 quarters · filed 2014-05-14 | -$2.00K 10-Q · filed 2013-08-14 | ||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | -$80.45K derived: sum of 2 quarters · filed 2014-05-14 | $1.10K derived: sum of 3 quarters · filed 2014-05-14 | $1.10K derived: sum of 4 quarters · filed 2014-05-14 | -$2.00K 10-Q · filed 2013-05-15 | ||||||
| 2012-12-31 | -$80.45K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $1.10K derived: sum of 2 quarters · filed 2014-03-27 | $1.10K derived: sum of 3 quarters · filed 2014-03-27 | -$5.08K 10-K · filed 2014-03-27 | -$2.00K 10-K · filed 2013-03-28 | ||||||
| 2012-09-30 | $81.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $81.55K derived: sum of 2 quarters · filed 2013-11-12 | $75.38K 10-Q · filed 2013-11-12 | $70.45K derived: sum of 4 quarters · filed 2013-11-12 | $78.45K 10-Q/A · filed 2013-01-22 | ||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$6.18K 10-Q · filed 2013-08-14 | -$11.10K derived: sum of 3 quarters · filed 2013-08-14 | ||||||||
| 2012-03-31 | -$6.18K 10-Q · filed 2013-05-15 | -$11.10K derived: sum of 2 quarters · filed 2013-05-15 | |||||||||
| 2011-12-31 | -$4.92K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | -$183.92K 10-K · filed 2013-03-28 | |||||||||
| 2011-09-30 | -$179.00K 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |